Drug-induced cataract

DRUGADVERS_CATAR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H26.3# 1 out of 7 registries used, show all original rules.	1000
4. Check minimum number of events None	1000
5. Include endpoints None	1000
6. Filter based on genotype QC (FinnGen only)	871

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_CATAR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H263
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced cataract based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4232	2397	1803
Only index persons	3685	2140	1545
Unadjusted period prevalence (%)
Whole population	0.06	0.07	0.05
Only index persons	0.07	0.08	0.06
Median age at first event (years)
Whole population	56.28	56.55	55.83
Only index persons	55.90	56.26	55.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	871	522	349
Unadjusted period prevalence (%)	0.18	0.19	0.16
Median age at first event (years)	55.14	54.39	56.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
902: Matched controls
9020

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AX01

ATC

azathioprine; systemic

22.3

321.6

261

162

Z96.1

ICD-10 Finland

Presence of intraocular lens

12.2

318.0

456

699

H26.3

ICD-10 Finland

Drug-induced cataract

+∞

307.7

901

L04AA06

ATC

mycophenolic acid; systemic

40.9

307.7

214

127

Kela drug reimbursment

Transplant complication

52.1

307.7

203

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

19.1

307.7

737

1711

L04AA01

ATC

[U] ciclosporin

61.5

287.6

162

H02AB04

ATC

methylprednisolone; systemic

9.5

251.2

429

785

L04AD01

ATC

ciclosporin; systemic

33.8

248.9

164

Z94.0

ICD-10 Finland

Kidney transplant status

54.6

241.4

139

H20.1

ICD-10 Finland

Chronic iridocyclitis

47.5

214.1

127

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

24.3

188.4

139

L04AD02

ATC

tacrolimus; systemic

39.0

186.1

116

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

7.9

181.5

323

596

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

23.8

176.3

131

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

9.2

175.8

252

363

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

12.3

169.7

186

187

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

48.2

168.1

H26.2

ICD-10 Finland

Complicated cataract

32.6

151.0

L01BA01

ATC

methotrexate; systemic

13.4

149.6

151

133

H26.4

ICD-10 Finland

After-cataract

7.4

143.9

253

452

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.4

137.2

576

2214

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

48.7

136.4

137

Kela drug reimbursment

Uraemia requiring dialysis

42.3

133.5

A12AA04

ATC

calcium carbonate; oral

23.3

132.2

A11CC03

ATC

alfacalcidol; systemic

17.1

131.2

113

TK800

NOMESCO Finland

Hemodialysis

17.8

126.1

106

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

4.9

123.5

521

1968

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

56.5

119.7

C03CA01

ATC

furosemide; systemic

4.7

116.6

449

1566

L04AX03

ATC

methotrexate; systemic

6.1

116.0

249

534

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

27.0

113.5

CJB10

NOMESCO Finland

Laser discission of secondary cataract

7.0

112.9

197

344

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.4

112.1

687

3369

Z49.1

ICD-10 Finland

Extracorporeal dialysis

23.6

111.9

H26.02

ICD-10 Finland

Presenil cataract

11.9

110.8

119

114

M05BA04

ATC

alendronic acid; oral

6.5

110.1

210

401

H02AB06

ATC

prednisolone; systemic

4.9

105.1

668

3303

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

7.7

104.7

163

251

H02AB09

ATC

hydrocortisone; systemic

14.1

104.1

N18.0

ICD-10 Finland

End-stage renal disease

33.8

102.5

B05DA

ATC

Isotonic solutions

36.9

98.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.0

98.7

168

284

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

6.6

97.8

179

326

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.9

97.6

280

762

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

28.4

96.9

V03AE01

ATC

polystyrene sulfonate; oral

24.8

96.3

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

27.3

95.5

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.7

94.4

170

304

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

26.9

93.5

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.6

92.8

145

223

B03XA02

ATC

darbepoetin alfa; parenteral

13.6

92.8

B03XA01

ATC

erythropoietin; parenteral

26.9

83.6

WX100

NOMESCO Finland

Conjunctival surface anesthesia

4.7

82.0

236

636

B05DB

ATC

Hypertonic solutions

37.8

80.2

N18.8

ICD-10 Finland

Other chronic renal failure

13.5

77.8

Z49.2

ICD-10 Finland

Other dialysis

33.0

77.2

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

9.3

75.1

113

P01BA02

ATC

hydroxychloroquine; oral

5.1

74.9

184

434

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

16.4

73.2

S01BA04

ATC

prednisolone; ophthalmic

11.6

72.3

Z49.0

ICD-10 Finland

Preparatory care for dialysis

20.9

71.7

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.3

67.9

125

226

J01MA12

ATC

levofloxacin; systemic

3.7

67.5

287

1011

S01BC05

ATC

ketorolac; ophthalmic

8.6

67.1

115

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.4

67.0

200

548

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.9

66.8

133

259

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.4

66.1

197

539

H02AB07

ATC

prednisone; oral

4.0

66.0

232

716

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

5.0

63.1

152

350

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.3

61.2

348

1457

R50.9

ICD-10 Finland

Fever, unspecified

3.6

60.4

251

864

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

7.7

59.8

125

S01EC01

ATC

acetazolamide; systemic

10.7

59.1

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

24.4

58.6

S01BA01

ATC

dexamethasone; ophthalmic

7.2

58.3

138

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

58.2

256

912

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.0

58.1

145

ZX120

NOMESCO Finland

Intravenous

4.2

57.1

174

481

S01ED01

ATC

timolol; ophthalmic

8.2

56.4

103

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.3

56.2

282

1087

S01ED51

ATC

timolol, combinations; ophthalmic

4.7

55.1

142

344

A07AA02

ATC

nystatin; oral

5.3

54.4

119

251

A07EC01

ATC

sulfasalazine; oral, rectal

4.4

53.2

152

399

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

7.1

52.2

125

J01FF01

ATC

clindamycin; systemic

2.9

52.0

364

1685

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

19.9

51.2

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

7.5

50.3

108

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

50.1

386

1873

H25.8

ICD-10 Finland

Other senile cataract

4.0

50.1

161

460

L88

ICPC

Rheumatoid/seropositive arthritis

5.7

49.6

188

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.8

49.5

514

2904

TPH04

NOMESCO Finland

Cathetrisation of vein

3.0

48.5

308

1344

L04AA13

ATC

[U] leflunomide

7.7

48.0

L04AB04

ATC

adalimumab; parenteral

8.1

47.7

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

7.0

47.0

113

S01EA05

ATC

brimonidine; ophthalmic

8.7

46.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.8

46.0

112

258

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.7

45.6

120

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.8

45.5

161

491

XCK10

NOMESCO Finland

Photography of fundus of eye

3.8

44.6

153

456

M01CB01

ATC

sodium aurothiomalate; parenteral

14.3

44.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.6

43.5

119

J01MA02

ATC

ciprofloxacin; systemic

2.6

43.4

447

2466

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.0

42.3

208

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.9

41.5

243

1003

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

11.0

41.4

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.1

41.3

196

B07.9

ICD-10 Finland

Verruca simplex

5.7

40.6

149

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.2

40.2

122

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.7

39.9

146

453

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.3

39.7

177

623

Z2446

NOMESCO Finland

Social worker

4.0

39.3

124

347

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.8

38.5

208

A41.9

ICD-10 Finland

Sepsis, unspecified

6.0

38.4

124

S01BA07

ATC

fluorometholone; ophthalmic

9.8

38.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.4

38.1

155

515

M04AA01

ATC

allopurinol; systemic

3.3

37.7

170

601

A05AA02

ATC

ursodeoxycholic acid; oral

9.6

37.7

GD1AD

NOMESCO Finland

Thorax CT examination

4.0

37.1

114

313

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.4

36.9

151

ZXA05

NOMESCO Finland

Left side

2.6

36.8

295

1419

R03AC12

ATC

salmeterol; inhalant

5.0

36.7

183

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

14.9

36.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

36.6

224

940

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.7

36.1

126

378

NF1AA

NOMESCO Finland

Hip X-ray examination

3.5

36.0

136

430

N02AX02

ATC

tramadol; systemic, rectal

2.4

35.9

486

2959

K65.0

ICD-10 Finland

Acute peritonitis

14.2

35.8

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.8

35.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.2

35.6

168

609

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.3

34.7

153

532

R03DA04

ATC

theophylline; systemic, rectal

4.8

34.5

180

ZXD05

NOMESCO Finland

Urgent procedure

2.4

34.5

343

1815

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.7

34.5

126

J01MA14

ATC

moxifloxacin; systemic

3.4

33.9

138

457

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.1

33.8

155

WX002

NOMESCO Finland

Sedation and analgesia

2.6

33.7

241

1091

A46

ICD-10 Finland

Erysipelas

2.9

33.5

190

763

ZXA00

NOMESCO Finland

Right side

2.4

33.1

311

1599

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

33.1

244

1120

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

11.7

32.8

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.7

32.8

116

350

S97

ICPC

Chronic ulcer skin

3.9

32.8

105

296

V03AE02

ATC

sevelamer; oral

39.0

32.7

XCK00

NOMESCO Finland

Perimetry

4.2

32.4

242

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.7

32.3

115

S01BC03

ATC

diclofenac; ophthalmic

7.0

32.1

WX140

NOMESCO Finland

Parabulbar anesthesy

4.4

31.7

210

M05BA07

ATC

risedronic acid; oral

5.9

31.7

103

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

4.5

31.4

190

TGC00

NOMESCO Finland

Bronchial lavation

5.8

31.0

105

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.1

30.6

148

542

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

30.4

179

730

UJF32

NOMESCO Finland

Coloscopy

2.4

30.4

302

1582

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.5

30.3

A02BC02

ATC

pantoprazole; systemic

2.5

30.2

697

5173

196

Kela drug reimbursment

Paricalcitol and cinacalcet

33.9

30.2

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.7

30.2

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.1

30.1

139

495

WW500

NOMESCO Finland

Blood transfusion

4.8

29.9

155

CS494

NOMESCO Finland

Other visual field testing

5.9

29.9

XG410

NOMESCO Finland

Flow-volume spirometry

4.5

29.9

180

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.8

29.8

102

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.1

29.7

143

522

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

5.5

29.2

111

ZXA10

NOMESCO Finland

Bilateral

2.6

29.2

216

987

H25.1

ICD-10 Finland

Senile nuclear cataract

2.4

29.0

281

1451

UKC02

NOMESCO Finland

Cystoscopy

2.7

28.8

180

756

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.2

28.5

C08CA05

ATC

nifedipine; systemic

4.0

28.2

229

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.2

28.1

202

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

28.0

114

376

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

103.4

27.8

C08CA02

ATC

felodipine; oral

3.2

27.7

122

422

WW200

NOMESCO Finland

Immunization

5.6

27.6

102

E0000UV, ,

ATC

2.1

27.6

449

2848

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.5

27.5

216

1012

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

6.8

27.5

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

27.4

293

1571

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

27.3

458

2935

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

9.7

27.2

A12AA12

ATC

[U] calcium acetate

144.3

26.8

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

25.6

26.8

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.5

26.5

102

A07AA09

ATC

vancomycin; oral

9.0

26.4

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

38.0

26.3

H30.2

ICD-10 Finland

Posterior cyclitis

38.0

26.3

Z94.4

ICD-10 Finland

Liver transplant status

38.0

26.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

26.2

280

1497

L01AA01

ATC

cyclophosphamide; systemic

32.1

26.1

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.4

26.0

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

10.0

26.0

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

24.9

25.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.8

25.8

132

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.0

25.7

211

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.8

25.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

25.6

155

638

R03AC13

ATC

formoterol; inhalant

3.9

25.5

217

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.9

25.5

133

506

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

25.9

25.4

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

25.4

231

1151

C02CA01

ATC

prazosin; oral

9.7

25.4

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

8.2

25.3

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

7.4

25.2

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

27.1

25.0

M05BX04

ATC

denosumab; parenteral

3.5

25.0

284

205

Kela drug reimbursment

Chronic hypertension

2.2

24.8

263

1397

S01FA04

ATC

cyclopentolate; ophthalmic

8.9

24.6

R03BB04

ATC

tiotropium bromide; inhalant

2.9

24.6

131

503

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.0

24.6

121

445

TK810

NOMESCO Finland

Hemofiltration

25.2

24.5

JN4AD

NOMESCO Finland

Body CT examination

2.7

24.5

152

633

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.1

24.3

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

5.4

24.3

N02AA05

ATC

oxycodone; systemic

2.4

24.3

209

1015

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

24.1

158

676

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

23.9

179

815

RS220, ,

NOMESCO Finland

7.6

23.9

C07AB02

ATC

metoprolol; systemic

2.4

23.7

204

990

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.0

23.4

187

H26.9

ICD-10 Finland

Cataract, unspecified

6.4

23.3

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

23.3

182

844

ZZA00

NOMESCO Finland

Split skin graft

4.9

22.9

112

M05BB03

ATC

alendronic acid and colecalciferol; oral

5.8

22.7

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.5

22.7

245

SPAT1229

SPAT

Assessment of need for aid

3.2

22.1

306

TK820

NOMESCO Finland

Peritoneal dialysis

22.9

21.8

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.8

21.7

188

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

21.6

C08CA01

ATC

amlodipine; oral

2.0

21.6

392

2520

J46

ICD-10 Finland

Status asthmaticus

4.7

21.5

114

H05AA02

ATC

teriparatide; parenteral

27.2

21.4

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

23.8

21.4

114

Kela drug reimbursment

Glaucoma

3.0

21.4

102

368

A12BA01

ATC

potassium chloride; oral

4.5

21.3

123

TNG10

NOMESCO Finland

Puncture of knee

7.7

21.3

H05BX01

ATC

cinacalcet; oral

17.1

21.1

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.4

21.0

170

799

N19

ICD-10 Finland

Unspecified kidney failure

4.2

21.0

142

A07EA06

ATC

budesonide; oral, local oral

3.9

20.8

170

R06.0

ICD-10 Finland

Dyspnoea

2.0

20.8

294

1727

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

16.3

20.7

7151

FHL

Kidney transplantation

214.8

20.7

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

112.7

20.6

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.9

20.4

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.1

20.4

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.1

20.4

Z94.2

ICD-10 Finland

Lung transplant status

49.2

20.2

A10AC01

ATC

insulin (human); parenteral

3.0

20.2

345

318

Kela drug reimbursment

Teriparatide

21.4

20.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.5

19.9

138

603

XG466

NOMESCO Finland

Sleep oxymetry

4.4

19.7

118

UJF30

NOMESCO Finland

Ileoscopy through colon

2.5

19.6

133

575

J45.1

ICD-10 Finland

Nonallergic asthma

2.9

19.6

351

C07AG02

ATC

carvedilol; oral

3.2

19.6

274

J01CF02

ATC

cloxacillin; systemic

5.6

19.4

U14

ICPC

Kidney symptom/complaint

6.1

19.3

RD210, ,

NOMESCO Finland

5.7

19.3

L04AA17

ATC

[U] adalimumab

47.1

19.3

R03BB01

ATC

ipratropium bromide; inhalant

4.3

19.2

125

L04AB01

ATC

etanercept; parenteral

6.5

18.9

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

18.9

250

1425

J96.1

ICD-10 Finland

Chronic respiratory failure

5.5

18.9

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

18.8

101

388

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.7

18.8

173

M81.4

ICD-10 Finland

Drug-induced osteoporosis

19.2

18.7

J05AB11

ATC

valaciclovir; oral

2.2

18.7

175

872

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.1

18.7

J01DB01

ATC

cefalexin; oral

2.4

18.6

781

6561

XCH00

NOMESCO Finland

Eye pressure measurement

3.5

18.5

199

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.2

18.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

18.4

530

3895

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.8

18.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

18.3

366

2395

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

45.0

18.3

S01EC04

ATC

brinzolamide; ophthalmic

3.8

18.3

157

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.1

18.2

269

E000001, ,

ATC

2.1

18.2

206

1106

A02BC01

ATC

omeprazole; systemic

2.0

18.2

268

1584

ZX108

NOMESCO Finland

Inhalation

14.7

18.2

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

33.7

18.0

C02EA02, ,

ATC

4.2

18.0

118

C08CA03

ATC

isradipine; systemic

7.8

17.9

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

7.4

17.9

R60.0

ICD-10 Finland

Localized oedema

2.4

17.8

142

660

J45.8

ICD-10 Finland

Mixed asthma

4.3

17.7

115

L04AA05

ATC

[U] tacrolimus

97.0

17.6

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.0

17.5

129

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

29.4

17.5

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.5

17.4

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

19.1

17.4

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

17.4

151

728

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

17.3

111

467

C03DA01

ATC

spironolactone; oral

2.4

17.2

132

603

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

17.2

194

1039

R4190

NOMESCO Finland

Nutritional therapy

3.4

17.1

189

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

16.3

17.1

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

32.2

17.1

TQW99

NOMESCO Finland

Other minor procedure on skin

3.2

17.1

236

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

51.0

17.0

C09AA02

ATC

enalapril; systemic

2.1

17.0

189

1006

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

16.8

110

466

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

64.6

16.8

R4110

NOMESCO Finland

Physiotherapy

1.9

16.6

290

1805

Z99.2

ICD-10 Finland

Dependence on renal dialysis

91.8

16.6

R03AC03

ATC

terbutaline; inhalant

2.2

16.5

151

743

C07AB07

ATC

bisoprolol; oral

1.8

16.5

455

3258

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

16.5

306

1942

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

16.5

331

R03DC01

ATC

zafirlukast; oral

5.6

16.3

M45

ICD-10 Finland

Ankylosing spondylitis

4.6

16.3

H40.0

ICD-10 Finland

Glaucoma suspect

2.7

16.2

375

K83.0

ICD-10 Finland

Cholangitis

6.9

16.2

M10.9

ICD-10 Finland

Gout, unspecified

2.9

16.2

288

A10AB05

ATC

insulin aspart; parenteral

2.7

16.2

364

J01FA06

ATC

roxithromycin; oral

1.8

16.1

385

2635

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

16.1

166

N03AX16

ATC

[U] pregabalin

1.9

16.1

243

1439

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

5.2

16.1

B01AA03

ATC

warfarin; systemic

2.2

16.1

160

814

R03BA02

ATC

budesonide; inhalant

2.0

16.0

198

1093

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

21.4

16.0

WZA10

NOMESCO Finland

Extensive medical or dental certificate

5.8

15.9

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

61.1

15.8

WZC30

NOMESCO Finland

Teaching

2.1

15.8

179

957

I50.9

ICD-10 Finland

Heart failure, unspecified

2.4

15.8

123

565

KBV00

NOMESCO Finland

Insertion of stent into ureter

13.2

15.7

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

15.7

375

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

17.6

15.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

15.6

104

444

H02AB08

ATC

triamcinolone; systemic

22.5

15.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.8

15.5

300

L01BB01, ,

ATC

162.7

15.5

S01EE03

ATC

bimatoprost; ophthalmic

4.8

15.5

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

15.5

402

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

15.5

148

740

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

15.5

208

1182

R03DC03

ATC

montelukast; oral

2.1

15.5

184

1001

JJC00

NOMESCO Finland

Allogenic transplantation of liver

38.8

15.4

SPAT1254

SPAT

Administration of medicine

2.2

15.4

144

714

ZX112

NOMESCO Finland

Subcutaneous

4.4

15.4

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.1

15.4

229

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

5.1

15.3

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.1

15.3

110

WX199

NOMESCO Finland

Other local analgesia

3.8

15.3

133

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

29.2

15.2

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.5

15.2

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.8

15.1

129

SPAT1262

SPAT

Handing over of treatment supplies

2.1

15.1

176

949

WX204

NOMESCO Finland

Axillary plexus blockaced

3.5

15.1

158

H43.1

ICD-10 Finland

Vitreous haemorrhage

4.4

15.1

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.9

15.1

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.2

15.0

205

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

15.0

385

2676

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

6.6

15.0

M13.9

ICD-10 Finland

Arthritis, unspecified

2.6

15.0

384

EBA10

NOMESCO Finland

Operative extraction of tooth

2.3

15.0

129

618

JN4BD

NOMESCO Finland

Extensive body CT

2.4

15.0

116

531

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.9

14.9

121

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

4.4

14.9

SPAT1263

SPAT

Sampling

1.8

14.8

388

2710

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

57.7

14.8

C02AC05

ATC

moxonidine; oral

3.2

14.8

191

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.8

14.7

291

K06.18

ICD-10 Finland

Another gingival hyperplasia

18.8

14.7

M05BA01

ATC

etidronic acid; systemic

18.8

14.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

14.7

125

595

V03AE03

ATC

lanthanum carbonate; oral

21.5

14.7

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

14.7

295

1906

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

14.6

157

821

A07EC02

ATC

mesalazine; oral, rectal

2.9

14.4

249

ZY010

NOMESCO Finland

Hospital outpatient

2.9

14.4

249

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

14.4

249

1535

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.7

14.3

J01DA01

ATC

[U] cefalexin

1.8

14.3

565

4413

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

14.3

365

2526

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

22.7

14.3

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

6.3

14.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

14.2

161

858

212

Kela drug reimbursment

Gout

5.8

14.2

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.8

14.2

291

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.4

14.1

155

GDG10

NOMESCO Finland

Bilateral transplantation of lung

43.2

14.1

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

43.2

14.1

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

12.2

14.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

14.1

280

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

5.5

14.1

CKC12

NOMESCO Finland

Photocoagulation of retina

3.3

14.1

176

Z3226

NOMESCO Finland

Physiotherapist

2.0

14.0

189

1072

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.3

14.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

14.0

125

608

J05AB01

ATC

aciclovir; systemic

1.9

13.9

221

1323

A41.8

ICD-10 Finland

Other specified sepsis

5.0

13.9

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

24.2

13.8

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

13.8

220

1320

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

6.6

13.7

M05BA06

ATC

ibandronic acid; systemic

4.6

13.6

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

76.3

13.6

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

13.6

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.1

13.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

13.4

335

2292

AA1AD

NOMESCO Finland

CT of head and brain

1.8

13.4

277

1795

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.1

13.4

192

J01EA01

ATC

trimethoprim; systemic

1.8

13.4

239

1483

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

14.1

13.3

A02BC05

ATC

esomeprazole; systemic

1.7

13.2

393

2819

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

40.7

13.2

NHQ40

NOMESCO Finland

Amputation of toe

5.6

13.1

321

Kela drug reimbursment

Paricalcitol and cinacalcet

11.2

13.1

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.3

13.0

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

5.3

13.0

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.4

13.0

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.1

13.0

RS221, ,

NOMESCO Finland

5.1

13.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

13.0

299

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

22.9

12.9

R11

ICD-10 Finland

Nausea and vomiting

2.3

12.9

451

J02AC01

ATC

fluconazole; systemic

1.7

12.8

367

2599

S01AX11

ATC

[U] ofloxacin

3.7

12.8

115

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.4

12.8

S18

ICPC

Laceration/cut

1.7

12.8

451

3373

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

14.3

12.8

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

12.8

125

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.4

12.7

H16.9

ICD-10 Finland

Keratitis, unspecified

4.9

12.7

H3603, E103,

ICD-10 Finland

15.7

12.7

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.5

12.7

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

70.9

12.6

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

70.9

12.6

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

32.5

12.6

R31

ICD-10 Finland

Unspecified haematuria

2.3

12.6

100

462

I15.0

ICD-10 Finland

Renovascular hypertension

17.6

12.5

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

12.5

335

WX202

NOMESCO Finland

Supraclavicular plexus blockade

5.1

12.5

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

131.8

12.5

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

4.6

12.4

A06AD11

ATC

lactulose; oral

2.1

12.4

135

708

P01AB01

ATC

metronidazole; oral, rectal

1.7

12.4

378

2717

ZXE00

NOMESCO Finland

One hour or less

1.7

12.3

355

2511

N30.0

ICD-10 Finland

Acute cystitis

1.9

12.3

164

923

B01AB05

ATC

enoxaparin; parenteral

1.7

12.3

295

1986

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

12.3

191

1132

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

38.1

12.2

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

12.6

12.2

C08CA13

ATC

lercanidipine; oral

2.0

12.1

148

808

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

12.1

255

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

18.3

12.1

L04AA11

ATC

[U] etanercept

18.3

12.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.3

12.1

S01EA03

ATC

apraclonidine; ophthalmic

8.8

12.1

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.3

12.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.1

12.0

177

TQW80

NOMESCO Finland

Local dermatologic skincare

3.9

12.0

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

5.1

12.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

12.0

139

745

WX892

NOMESCO Finland

Monitored bed care

2.4

12.0

380

CKD40

NOMESCO Finland

Endophotocoagulation of retina

4.9

12.0

WX882

NOMESCO Finland

High dependency care

3.6

11.9

116

N03AX12

ATC

[U] gabapentin; oral

1.9

11.9

170

979

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.0

11.9

189

A02BA02

ATC

ranitidine; systemic

1.9

11.8

183

1081

R06AE07

ATC

cetirizine; oral

1.6

11.8

405

2988

S01EE01

ATC

latanoprost; ophthalmic

2.7

11.8

259

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

16.7

11.7

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

12.8

11.7

JJ5AT, ,

NOMESCO Finland

65.8

11.6

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.1

11.6

159

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

11.6

243

KAC00

NOMESCO Finland

Nephrectomy

23.2

11.6

B01AB04

ATC

dalteparin; parenteral

2.9

11.6

192

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.0

11.6

181

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.2

11.6

149

D11AH01

ATC

tacrolimus; topical

9.4

11.5

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

11.5

286

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

+∞

11.5

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

121.5

11.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

11.4

341

2423

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

11.4

216

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.6

11.4

257

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

11.4

219

1381

H25.0

ICD-10 Finland

Senile incipient cataract

2.6

11.3

288

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

11.3

133

716

K50.8

ICD-10 Finland

Other Crohn disease

4.4

11.3

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

11.3

162

SPAT1255

SPAT

Intravenous administration of medicine

2.6

11.3

283

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

11.3

430

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

4.7

11.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

11.2

353

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.9

11.1

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

11.1

406

J01CA04

ATC

amoxicillin; systemic

1.9

11.1

745

6488

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

5.8

11.0

TQW40

NOMESCO Finland

Remowal of suture of skin

2.4

11.0

342

K51.8

ICD-10 Finland

Other ulcerative colitis

4.6

11.0

H15.1

ICD-10 Finland

Episcleritis

4.7

11.0

SPAT1216

SPAT

Assessment of functional ability

2.0

11.0

139

768

SPAT1211

SPAT

Application of soft bandage

2.3

10.9

415

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

43.9

10.9

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

43.9

10.9

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

43.9

10.9

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.3

10.9

128

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.1

10.9

111

566

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

10.9

201

1250

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

4.3

10.9

N05CF01

ATC

zopiclone; oral

1.7

10.9

292

2015

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.0

10.9

171

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

10.8

282

X58

ICD-10 Finland

Exposure to other specified factors

1.9

10.8

159

922

R03BA08

ATC

ciclesonide; inhalant

2.2

10.8

471

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

9.0

10.8

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

9.0

10.8

QXB99, ,

SPAT

3.3

10.8

124

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

10.8

112

576

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.6

10.8

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.0

10.7

172

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

28.4

10.7

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.6

10.7

100

B02.9

ICD-10 Finland

Zoster without complication

2.4

10.7

322

J01MA01

ATC

ofloxacin; systemic

2.3

10.6

367

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.4

10.6

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.3

10.6

355

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

10.6

202

A01AB10

ATC

natamycin; local oral

3.6

10.5

101

A02BC03

ATC

lansoprazole; oral

1.7

10.5

266

1804

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.2

10.5

H05BX02

ATC

paricalcitol; systemic

111.3

10.4

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

111.3

10.4

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

+∞

10.4

L01BB02

ATC

mercaptopurine; oral

5.5

10.4

J45

ICD-10 Finland

Asthma

2.1

10.4

108

555

R03AC02

ATC

salbutamol; inhalant

1.6

10.4

509

4048

6BA02, ,

NOMESCO Finland

16.3

10.4

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

8.3

10.4

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.4

10.4

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

10.8

10.3

L28

ICPC

Limited function/disability (L)

1.8

10.3

174

1053

R4180

NOMESCO Finland

Podiatric therapy

5.0

10.3

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

5.0

10.3

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

23.7

10.3

A28

ICPC

Limited function/disability NOS

1.9

10.3

153

891

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

10.2

253

S01KA02

ATC

hypromellose; ophthalmic

4.3

10.1

Z3231

NOMESCO Finland

Registered nurse

1.7

10.1

252

1699

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.3

10.1

336

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

10.1

119

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

10.1

175

1067

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

3.5

10.1

104

A04AA01

ATC

ondansetron; systemic, rectal

2.2

10.1

450

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

4.5

10.1

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

14.8

10.0

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

40.5

10.0

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

40.5

10.0

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.6

10.0

XPX08

NOMESCO Finland

Intraoperative flow measurement

7.7

9.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

9.9

410

3124

M31.3

ICD-10 Finland

Wegener granulomatosis

16.9

9.9

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

9.9

186

WX872

NOMESCO Finland

Intensive care

2.6

9.9

221

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

12.4

9.9

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.2

9.9

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.1

9.8

142

A02BA03

ATC

famotidine; systemic

3.1

9.8

142

5AB14, ,

NOMESCO Finland

20.3

9.8

N28

ICPC

Limited function/disability (N)

4.6

9.8

SPAT1325

SPAT

Vaccination

1.6

9.8

286

2005

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

9.7

9.8

R06.2

ICD-10 Finland

Wheezing

2.8

9.8

187

A01AB09

ATC

miconazole; local oral

2.2

9.8

421

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.2

9.7

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

7.5

9.7

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.7

9.7

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.5

9.7

241

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

13.5

9.7

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

9.7

138

H33.0

ICD-10 Finland

Retinal detachment with retinal break

3.1

9.7

138

QBA10

NOMESCO Finland

Incision of skin of trunk

5.4

9.7

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

9.7

200

S01EC54

ATC

brinzolamide, combinations; ophthalmic

5.1

9.6

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.5

9.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

8.5

9.6

NDG30

NOMESCO Finland

Fusion of wrist, total

11.5

9.6

H35.36

ICD-10 Finland

Macular cyst

10.2

9.5

A10BH05

ATC

linagliptin; oral

2.6

9.5

219

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

15.2

9.5

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

9.5

306

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

9.5

156

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

9.5

281

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.3

9.5

313

D06BB04

ATC

podophyllotoxin; topical

2.7

9.5

196

ZXD20

NOMESCO Finland

Day surgery

1.9

9.5

123

684

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

9.5

496

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.7

9.4

185

5602

FHL

Internal fistula (eg Cimino)

101.1

9.4

187

Kela drug reimbursment

MPA

101.1

9.4

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

101.1

9.4

N02AC04

ATC

dextropropoxyphene; oral

3.1

9.4

135

K51.5

ICD-10 Finland

Left sided colitis

3.2

9.4

114

PC6DE, ,

NOMESCO Finland

+∞

9.4

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

9.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

9.4

151

899

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

9.4

198

1275

K92.1

ICD-10 Finland

Melaena

2.6

9.4

215

S01FA02

ATC

scopolamine; ophthalmic

8.2

9.4

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.1

9.3

125

1XC02, ,

NOMESCO Finland

10.8

9.3

J01CA08

ATC

pivmecillinam; oral

1.6

9.3

347

2573

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.4

9.2

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.2

9.2

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.8

9.2

Z94.1

ICD-10 Finland

Heart transplant status

13.8

9.2

N06AB04

ATC

citalopram; systemic

1.7

9.2

190

1216

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

4.3

9.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

9.1

385

KBV10

NOMESCO Finland

Removal of stent from ureter

8.4

9.1

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

11.6

9.1

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.1

9.1

N06AA09

ATC

amitriptyline; systemic

2.0

9.1

511

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

9.2

9.1

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.7

9.0

195

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

10.2

9.0

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

37.1

9.0

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

37.1

9.0

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

37.1

9.0

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

37.1

9.0

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

37.1

9.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

9.0

117

650

E87.5

ICD-10 Finland

Hyperkalaemia

4.3

9.0

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.6

9.0

208

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

24.3

8.9

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

24.3

8.9

SAA04

NOMESCO Finland

Special examination of mouth

2.4

8.9

264

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

5.0

8.9

J01FA10

ATC

azithromycin; systemic

1.5

8.8

515

4193

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

10.8

8.8

L57.0

ICD-10 Finland

Actinic keratosis

2.0

8.8

101

538

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.6

8.8

204

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

7.3

8.8

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.6

8.7

602

Kela drug reimbursment

Children's severe malnutrition

14.2

8.7

M32

ICD-10 Finland

Systemic lupus erythematosus

50.5

8.7

V03AG01

ATC

sodium cellulose phosphate; systemic

50.5

8.7

L04AB06

ATC

golimumab; parenteral

7.7

8.7

NB1AD

NOMESCO Finland

Shoulder CT examination

4.0

8.6

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

8.6

208

1384

L95

ICPC

Osteoporosis

2.6

8.6

188

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

8.6

102

549

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.6

8.6

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.8

8.6

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

11.7

8.6

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.5

8.6

237

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

3.6

8.6

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.2

8.6

105

NDG74

NOMESCO Finland

Fusion of first IP joint

16.5

8.6

L84

ICD-10 Finland

Corns and callosities

2.9

8.5

143

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.5

8.5

R01AD08

ATC

fluticasone; nasal

1.6

8.5

257

1807

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

8.5

120

685

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

8.5

674

7462

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

20.2

8.5

KAS40

NOMESCO Finland

Excision of transplanted kidney

90.9

8.4

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

90.9

8.4

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.3

8.4

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

8.0

8.4

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

12.9

8.4

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.9

8.4

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.7

8.4

S01EE05

ATC

tafluprost; ophthalmic

2.8

8.4

156

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.8

8.4

156

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

8.3

292

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

8.3

241

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

8.3

414

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

8.3

421

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.3

8.3

L04AB05

ATC

certolizumab pegol; parenteral

14.6

8.2

SPAT1153

SPAT

Removal of sutures

1.6

8.2

275

1978

Z2221

NOMESCO Finland

Medical doctor

1.6

8.2

239

1665

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

8.2

251

1769

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

8.2

362

2766

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

8.2

230

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

8.2

445

3549

UJF92

NOMESCO Finland

Capsular endoscopy

3.5

8.1

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.8

8.1

E86

ICD-10 Finland

Volume depletion

3.4

8.1

49300

ICD-8 Finland

Asthma, bronchiale

3.4

8.1

R03BA05

ATC

fluticasone; inhalant

1.7

8.1

169

1081

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.2

8.1

A07DA03

ATC

loperamide; oral

3.0

8.1

125

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

33.7

8.1

L04AA10

ATC

[U] sirolimus

33.7

8.1

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

33.7

8.1

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

17.4

8.1

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

9.0

8.1

C02DE02, ,

ATC

10.1

8.0

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

10.1

8.0

ZXD00

NOMESCO Finland

Emergency procedure

3.2

8.0

104

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

8.0

189

1248

K65.9

ICD-10 Finland

Peritonitis, unspecified

22.2

8.0

M33.2

ICD-10 Finland

Polymyositis

22.2

8.0

J01MA06

ATC

norfloxacin; oral

1.8

8.0

116

667

JFB00

NOMESCO Finland

Partial resection of small intestine

4.3

8.0

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.8

8.0

143

SPAT1234

SPAT

Support of social functional capacity

2.6

7.9

184

S51.0

ICD-10 Finland

Open wound of elbow

4.7

7.9

3AC01, ,

NOMESCO Finland

7.9

M01CB03

ATC

auranofin; oral

7.9

C90.0

ICD-10 Finland

Multiple myeloma

6.2

7.9

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

7.9

179

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

7.8

WX212

NOMESCO Finland

Femoral plexus blockade

3.4

7.8

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

7.8

465

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

4.1

7.8

A10AB01

ATC

insulin (human); parenteral

2.9

7.8

133

RJ411, ,

NOMESCO Finland

9.5

7.8

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.7

7.8

162

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

7.8

101

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

6.4

7.7

H25.2

ICD-10 Finland

Senile cataract, morgagnian type

15.2

7.7

C09CA01

ATC

losartan; oral

1.6

7.7

227

1581

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

7.7

533

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

7.5

7.7

RS222, ,

NOMESCO Finland

4.6

7.7

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.8

7.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

7.7

165

1064

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.5

7.6

194

J01AA02

ATC

doxycycline; systemic

1.6

7.6

689

6066

J01CF01

ATC

dicloxacillin; systemic

12.0

7.6

KA3EB

NOMESCO Finland

Antegrade pyelography

12.0

7.6

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

25.2

7.6

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

25.2

7.6

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

6.2

7.6

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.4

7.6

J01XX08

ATC

linezolid; systemic

9.0

7.6

XKD00

NOMESCO Finland

Uroflowmetry

1.8

7.5

119

703

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

7.5

214

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

7.5

233

A10AE05

ATC

insulin detemir; parenteral

2.3

7.5

240

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.0

7.5

409

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

4.5

7.5

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

7.4

182

1212

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

80.7

7.4

M31.7

ICD-10 Finland

Microscopic polyangiitis

80.7

7.4

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

80.7

7.4

K06.10

ICD-10 Finland

Gingival fibromatosis

80.7

7.4

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

80.7

7.4

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

7.4

340

D07AB08

ATC

desonide; topical

1.9

7.4

100

563

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

7.4

267

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

7.4

122

731

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.5

7.4

185

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

7.3

173

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

7.3

294

TAB00

NOMESCO Finland

Lumbar puncture

2.4

7.3

210

WX890

NOMESCO Finland

Intesive care monitoring

8.5

7.3

3025

Kela drug reimbursment

Calcium carbonate

8.5

7.3

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

11.0

7.3

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

+∞

7.3

L03AA02

ATC

filgrastim; parenteral

2.8

7.3

127

N03AX14

ATC

levetiracetam; systemic

2.9

7.3

116

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

7.3

186

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

6.3

7.3

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

5.9

7.2

9531

FHL

Arthrodesis of the hand joint

15.9

7.2

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

15.9

7.2

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.7

7.2

148

942

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.6

7.2

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

30.3

7.2

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

30.3

7.2

S86.0

ICD-10 Finland

Injury of Achilles tendon

3.0

7.1

101

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.6

7.1

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.6

7.1

152

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

7.1

170

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.1

7.1

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.1

7.1

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

12.1

7.1

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

7.1

489

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.7

7.1

J01CF05

ATC

flucloxacillin; systemic

2.0

7.0

389

D02AX

ATC

Other emollients and protectives

2.8

7.0

124

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.5

7.0

NDL52

NOMESCO Finland

Tenosynovectomy of hand

7.1

7.0

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

7.1

7.0

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

7.0

113

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.4

7.0

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.9

7.0

J47

ICD-10 Finland

Bronchiectasis

3.4

7.0

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

7.0

376

WX402

NOMESCO Finland

General anaesthesia

1.6

7.0

204

1415

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.4

7.0

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.4

7.0

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.9

7.0

108

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

6.9

274

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.5

6.9

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.9

6.9

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.6

6.9

154

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

13.9

6.9

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.5

6.9

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.3

6.9

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.3

6.9

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.3

6.9

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

8.3

6.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

6.8

217

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.8

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

11.0

6.8

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

6.8

115

ZXC50

NOMESCO Finland

Cryotherapy

2.8

6.8

115

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

9.4

6.8

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.4

6.8

S01EC03

ATC

dorzolamide; ophthalmic

6.2

6.8

132

Kela drug reimbursment

Sarcoidosis

6.2

6.8

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.1

6.8

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.7

6.8

N17.8

ICD-10 Finland

Other acute renal failure

5.7

6.8

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.3

6.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

6.8

277

ZX197, ,

NOMESCO Finland

40.4

6.8

N03.2

ICD-10 Finland

Chronic nephritic syndrome, diffuse membranous glomerulonephritis

40.4

6.8

Q61.0

ICD-10 Finland

Congenital single renal cyst

40.4

6.8

B34.9

ICD-10 Finland

Viral infection, unspecified

2.8

6.8

121

B01.9

ICD-10 Finland

Varicella without complication

16.8

6.8

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.6

6.7

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.0

6.7

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.3

6.7

J01DC02

ATC

cefuroxime; systemic

2.2

6.7

251

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

6.7

403

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.7

6.7

133

N05BA04

ATC

oxazepam; oral

1.5

6.7

224

1600

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

6.7

319

A01AB04

ATC

amphotericin B; local oral

2.4

6.7

200

J20

ICD-10 Finland

Acute bronchitis

1.8

6.7

100

581

58209

ICD-8 Finland

Chronic nephritis, Unspecified

22.7

6.7

R03AC04

ATC

fenoterol; inhalant

22.7

6.7

N04.2

ICD-10 Finland

Nephrotic syndrome, diffuse membranous glomerulonephritis

22.7

6.7

ZX199

NOMESCO Finland

Other rote

22.7

6.7

J37.0

ICD-10 Finland

Chronic laryngitis

2.6

6.7

151

XX9XE

NOMESCO Finland

Other ultrasound examination

6.5

6.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.5

6.7

SPAT1301

SPAT

No procedures

1.5

6.7

253

1857

M81.8

ICD-10 Finland

Other osteoporosis

5.5

6.6

K03.66

ICD-10 Finland

Tooth plaque

1.9

6.6

441

H02AA02

ATC

fludrocortisone; oral

7.9

6.6

R03BA01

ATC

beclometasone; inhalant

1.7

6.6

117

714

S81.0

ICD-10 Finland

Open wound of knee

3.5

6.6

ZQZ00

NOMESCO Finland

Treatment of several skin areas

12.4

6.6

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

12.4

6.6

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.0

6.6

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.2

6.6

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

6.6

457

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.9

6.6

H01AC01

ATC

somatropin; parenteral

10.1

6.5

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.7

6.5

129

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.7

6.5

129

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

6.5

322

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

6.5

171

S09

ICPC

Infected finger/toe

2.6

6.5

147

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

6.5

268

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.2

6.5

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.9

6.5

107

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

5.8

6.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

6.5

232

1681

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

4.0

6.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

6.5

116

711

M01AH01

ATC

celecoxib; oral

1.6

6.4

157

1042

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

70.3

6.4

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

70.3

6.4

297, ,

Kela drug reimbursment

70.3

6.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

6.4

148

C08DA01

ATC

verapamil; systemic

2.4

6.4

185

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

14.4

6.4

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

14.4

6.4

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

14.4

6.4

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.8

6.4

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.1

6.4

H25.9

ICD-10 Finland

Senile cataract, unspecified

4.1

6.4

G62.8

ICD-10 Finland

Other specified polyneuropathies

6.6

6.4

H16.0

ICD-10 Finland

Corneal ulcer

2.2

6.3

244

L73.8

ICD-10 Finland

Other specified follicular disorders

5.2

6.3

C10AC01

ATC

colestyramine; oral

2.8

6.3

114

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.4

6.3

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.7

6.3

120

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

6.3

193

M10.0

ICD-10 Finland

Idiopathic gout

2.7

6.3

126

78900

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Albuminuria

18.2

6.3

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

18.2

6.3

7101

FHL

Needle biopsy in the operating room

+∞

6.3

9968A

ICD-9 Finland

Complications peculiar to certain specified procedures, Complications of transplanted organ

+∞

6.3

BE00A, ,

NOMESCO Finland

+∞

6.3

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

+∞

6.3

4059A

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA RENOVASCULARIS]

+∞

6.3

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

6.3

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

+∞

6.3

4AA09, ,

NOMESCO Finland

+∞

6.3

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

26.9

6.2

Q61.1

ICD-10 Finland

Polycystic kidney, autosomal recessive

26.9

6.2

D638, N189,

ICD-10 Finland

26.9

6.2

S01FA06

ATC

tropicamide; ophthalmic

26.9

6.2

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.6

6.2

148

977

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

6.2

163

XQ800

NOMESCO Finland

Prick test

2.0

6.2

357

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

6.2

127

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.0

6.2

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

6.2

343

C10AA04

ATC

fluvastatin; oral

1.9

6.2

393

H34.8

ICD-10 Finland

Other retinal vascular occlusions

3.3

6.2

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

6.3

6.2

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

6.3

6.2

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

6.3

6.2

TJF80

NOMESCO Finland

Ostomy education

5.4

6.2

C10AA01

ATC

simvastatin; oral

1.4

6.2

325

2536

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

6.2

160

1078

RS121, ,

NOMESCO Finland

7.7

6.1

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.8

6.1

RS311, ,

NOMESCO Finland

12.6

6.1

XX4BW, ,

NOMESCO Finland

12.6

6.1

CKA10

NOMESCO Finland

Biopsy of vitreous body

12.6

6.1

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.7

6.1

-, ,

ICD-10 Finland

3.2

6.0

JAH00

NOMESCO Finland

Laparotomy

2.7

6.0

117

S19

ICPC

Skin injury other

2.4

6.0

165

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.4

6.0

165

D68.9

ICD-10 Finland

Coagulation defect, unspecified

10.1

6.0

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

10.1

6.0

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.2

6.0

236

XF602

NOMESCO Finland

Bloodpressure monitoring

5.2

6.0

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

5.2

6.0

K11.2

ICD-10 Finland

Sialoadenitis

2.7

6.0

123

I95.1

ICD-10 Finland

Orthostatic hypotension

2.7

6.0

123

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.5

6.0

147

E000002, ,

ATC

1.8

6.0

546

S01AD03

ATC

aciclovir; ophthalmic

2.5

6.0

141

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026250) Tacrolimus [Mass/volume] in Blood

126

37.39

199.30

46.1

36.6

7.22

7.15

ug/l

0.06

110

(3010375) cycloSPORINE [Mass/volume] in Blood

119

45.54

198.79

37.7

28.6

112.70

139.92

ug/l

0.99

107

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

177

183

11.79

158.07

18.0

6.6

577.19

187.70

iu/ml

1.01

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

141

12.76

145.58

7.9

3.2

282.45

729.36

u/ml

0.79

(3020779) Urea [Moles/volume] in Serum or Plasma

294

729

5.50

116.58

30.3

7.3

11.79

9.15

mmol/l

4.98

287

705

(3042733) HLA Ab [Presence] in Serum

27.71

107.48

5.0

3.7

—

(40768446) Kidney Pathology biopsy report

23.98

100.44

2.5

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

353

1135

4.47

99.45

24.5

5.8

1.09

1.04

mmol/l

2.45

339

1055

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

12.09

92.61

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

11.70

91.48

2.5

2.4

22.98

43.03

iu/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

124

164

8.61

90.39

2.5

1.5

146.37

151.75

au/ml

0.14

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

129

185

7.97

87.73

2.5

1.5

—

(42870588) Differential panel, method unspecified - Blood

590

2898

3.99

87.60

20.9

6.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

157

283

6.51

86.20

15.3

3.7

1.95

1.43

mg/l

6.78

152

255

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

241

651

4.69

83.63

11.7

3.9

145.48

82.11

ng/l

3.62

217

578

(3006315) Basophils [#/volume] in Blood

730

4330

4.60

78.34

20.7

6.5

0.04

e9/l

0.03

681

3694

(3001604) Monocytes [#/volume] in Blood

728

4324

4.54

77.61

20.6

6.5

0.62

0.58

e9/l

5.10

679

3685

(3005719) IgG [Mass/volume] in Serum or Plasma

243

701

4.38

76.88

6.8

2.8

8.88

10.62

g/l

8.19

235

646

(3019198) Lymphocytes [#/volume] in Blood

731

4389

4.51

75.86

21.0

6.5

1.77

1.95

e9/l

3.13

688

3848

(3024471) HLA-A [Type]

24.91

75.73

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

353

1343

3.68

74.86

6.7

2.5

11.71

13.32

umol/l

4.76

339

1253

(3013115) Eosinophils [#/volume] in Blood

736

4468

4.52

74.48

21.7

6.8

0.18

0.20

e9/l

1.44

685

3889

(3024932) HLA-DR beta [Type]

24.42

73.77

1.1

1.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

352

1351

3.63

73.41

3.3

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

286

961

3.89

72.77

2.8

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

282

939

3.91

72.69

7.1

4.7

238.60

249.85

u/l

0.55

272

894

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

17.78

72.60

3.4

2.0

41154.31

88660.80

u/ml

—

(3023368) Bacteria identified in Blood by Culture

474

2220

3.39

71.31

8.9

4.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

115

182

7.10

71.18

2.1

1.3

293.60

266.49

u/ml

0.32

103

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

199

523

4.60

70.63

13.3

3.8

0.99

1.96

mmol/l

2.87

156

396

(3004789) Transferrin [Mass/volume] in Serum or Plasma

332

1260

3.59

69.93

6.8

2.5

2.22

2.33

g/l

2.81

317

1170

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

314

1160

3.62

68.80

7.0

2.5

21.97

23.10

0.73

302

1087

(3009343) pH of Capillary blood

210

588

4.35

68.50

14.0

3.9

7.42

0.20

198

492

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

209

585

4.35

68.19

2.6

1.6

—

(3019069) Monocytes/Leukocytes in Blood

676

4016

3.73

67.18

21.8

6.7

9.04

8.84

1.03

651

3777

(3042936) Bacteria identified in Isolate by Culture

317

1195

3.55

67.06

3.9

2.1

—

(3006504) Eosinophils/Leukocytes in Blood

674

4005

3.70

66.77

21.6

6.6

2.62

2.92

3.00

648

3764

(3018010) Neutrophils/Leukocytes in Blood

674

4007

3.70

66.67

20.5

6.5

59.48

56.70

7.93

654

3836

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

128

241

6.02

66.62

4.4

3.1

0.27

0.35

iu/ml

1.92

121

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

123

8.22

66.01

1.1

—

(3022096) Basophils/Leukocytes in Blood

668

3995

3.59

64.41

22.1

6.7

0.69

0.70

0.15

644

3747

(3002030) Lymphocytes/Leukocytes in Blood

675

4082

3.60

63.49

21.5

6.6

25.97

28.26

7.08

657

3879

(3013650) Neutrophils [#/volume] in Blood by Automated count

743

4794

4.12

62.73

26.4

10.0

4.43

4.03

e9/l

4.98

706

4169

(3027945) Reticulocytes/Erythrocytes in Blood

264

920

3.64

62.54

6.0

2.8

1.90

1.83

0.46

242

831

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

149

342

5.02

62.06

2.1

2.0

1.45

1.51

g/l

0.31

132

304

(3014148) Varicella zoster virus Ab [Titer] in Serum

117

8.12

62.05

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

224

705

3.90

61.65

5.3

2.8

71.78

72.29

e9/l

0.07

178

509

(3028026) IgM [Mass/volume] in Serum or Plasma

195

564

4.14

60.36

3.0

1.8

1.21

1.30

g/l

0.32

184

518

(3008757) Leukocyte morphology finding [Identifier] in Blood

9.37

58.96

5.0

4.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

17.21

58.55

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

22.53

58.07

1.0

—

(3022313) Gas panel - Capillary blood

161

420

4.45

57.00

15.1

4.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

147

361

4.67

56.16

3.1

1.4

27.33

9.85

iu/ml

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

609

3631

3.08

55.13

16.3

5.1

34.38

35.98

g/l

10.21

584

3424

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

113

226

5.57

54.84

3.5

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

622

3760

3.11

54.76

26.4

6.9

1.22

1.21

mmol/l

1.59

593

3493

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

123

269

5.14

53.95

3.3

1.6

0.22

0.24

g/l

1.95

117

256

(3017143) Hepatitis C virus Ab [Presence] in Serum

251

929

3.36

53.13

2.7

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

124

278

5.01

52.79

3.3

1.6

1.14

1.22

g/l

1.79

118

264

(3048929) Epstein Barr virus Ab [Presence] in Serum

126

290

4.89

51.97

2.0

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

658

4170

3.14

51.93

30.2

7.5

1.22

1.21

mmol/l

0.41

607

3641

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

122

275

4.97

51.57

1.9

1.5

0.70

0.09

iu/ml

0.72

(3012095) Magnesium [Moles/volume] in Serum or Plasma

330

1457

2.99

51.32

12.5

3.5

0.80

0.82

mmol/l

2.68

317

1382

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

113

240

5.24

51.18

3.7

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

155

6.34

50.98

3.4

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

411

2084

2.79

48.74

3.7

2.2

3.34

2.87

mg/l

3.01

373

1797

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

127

312

4.57

48.22

1.9

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

101

7.54

48.06

3.2

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

417

2144

2.76

47.92

7.4

2.7

368.57

339.87

umol/l

6.29

387

1901

(3019225) pH of Specimen

214

764

3.36

47.53

12.9

4.2

7.38

7.35

2.61

179

555

(3017181) Myelocytes/Leukocytes in Blood

211

757

3.33

46.39

8.7

4.6

0.63

0.97

1.95

128

238

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

277

1168

2.98

46.09

2.8

1.6

—

(3011412) CD3 cells [#/volume] in Blood

8.82

45.89

3.3

2.1

1181.48

1169.74

e6/l

0.03

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

119

290

4.58

45.56

3.4

2.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

10.54

45.49

3.6

2.5

159.75

236.51

e6/l

1.73

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

253

1022

3.05

45.37

2.8

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

7.71

45.01

3.3

1.9

—

(3002179) Metamyelocytes/Leukocytes in Blood

202

720

3.33

44.76

8.2

4.6

0.60

0.61

0.05

122

221

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

16.49

44.55

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

120

6.63

44.36

7.7

6.5

13.01

11.69

mg/l

1.67

115

(3000850) Epithelial cells [#/volume] in Urine

368

1836

2.70

44.06

7.7

2.6

4.14

5.41

e6/l

1.63

349

1680

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

600

3809

2.72

43.58

5.2

2.5

78.41

77.29

nmol/l

0.48

556

3440

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

14.39

43.58

4.3

2.7

0.59

0.60

mmol/l

0.24

(3021440) Promyelocytes/Leukocytes in Blood

200

720

3.28

43.50

8.7

4.7

0.04

0.14

2.11

116

199

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

390

2021

2.64

43.00

4.9

2.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

102

233

4.81

42.21

2.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

151

5.79

42.17

1.6

1.3

381.82

134.00

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

112

277

4.47

41.99

3.8

2.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

132

372

3.99

41.56

3.9

1.8

14.42

8.27

iu/ml

0.90

(3020630) Protein [Mass/volume] in Serum or Plasma

189

675

3.28

41.51

3.3

3.0

64.56

67.15

g/l

4.85

181

624

(3002032) Base excess in Venous blood by calculation

219

855

3.06

41.31

17.4

3.5

1.05

1.90

mmol/l

2.93

201

730

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

9.88

40.97

3.7

2.3

467.00

487.25

e6/l

0.10

(3028192) IgG subclass 2 [Mass/volume] in Serum

7.94

40.72

1.5

1.3

2.60

2.75

g/l

0.23

(3024139) IgG subclass 3 [Mass/volume] in Serum

7.94

40.72

1.5

1.3

0.38

g/l

0.03

(3027135) IgG subclass 1 [Mass/volume] in Serum

7.94

40.72

1.5

1.3

5.99

6.86

g/l

0.60

(3000991) Gas panel - Venous blood

203

766

3.13

40.56

22.9

9.4

—

(3037522) Nuclear Ab [Titer] in Serum

273

1214

2.79

40.42

1.8

1.4

617.78

496.53

titre

0.47

271

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

108

269

4.42

40.07

2.7

1.8

—

(4062490) Immunoglobulin typing, IgG

7.73

39.82

1.5

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

131

381

3.85

39.36

4.0

2.2

38.10

40.26

u/l

0.53

120

339

(44806118) Parainfluenza type 4 nucleic acid detection

121

6.19

39.35

3.1

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

121

6.19

39.35

3.1

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

121

6.19

39.35

3.1

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

121

6.19

39.35

3.1

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

175

615

3.29

39.32

1.8

1.5

—

(3045424) Erythrocytes [Presence] in Urine

137

412

3.74

39.21

4.0

2.2

0.00

0.01

estimate

0.50

125

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

5.25

39.18

2.4

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

235

4.61

39.01

2.4

1.2

7.62

6.80

iu/ml

—

(3012544) pH of Venous blood

221

894

2.95

38.90

17.5

3.6

7.37

7.38

2.00

157

504

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

162

547

3.39

38.81

19.0

3.5

23.54

24.36

mmol/l

2.97

162

541

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

4.81

38.47

2.6

1.5

—

(3037121) Protein [Mass/volume] in Urine

115

311

4.09

38.22

9.6

3.8

491.29

314.89

mg/l

0.81

133

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

120

337

3.95

37.84

2.7

2.0

2.50

2.18

ug/l

0.11

107

306

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

643

4393

2.61

37.35

16.3

7.0

9.64

11.42

umol/l

6.84

623

4210

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

179

658

3.15

37.17

5.3

2.7

50.70

68.27

ml/min/173m2

7.12

279

(3036481) Cortisol [Moles/volume] in Serum or Plasma

209

848

2.91

36.36

3.8

2.2

280.98

373.65

nmol/l

7.79

200

803

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

227

967

2.80

36.01

3.0

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

136

5.58

35.83

1.9

1.8

0.48

0.87

g/l

1.84

112

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

118

5.96

35.81

2.8

1.7

—

(3025159) Blasts/Leukocytes in Blood

189

734

2.99

35.53

8.5

5.0

0.01

0.17

1.75

104

184

(3032080) INR in Blood by Coagulation assay

569

3730

2.42

35.25

22.8

13.1

1.22

1.21

inr

0.13

485

3070

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

195

4.71

34.86

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

108

6.09

34.53

3.2

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

254

4.21

34.40

5.4

2.6

212.06

194.77

0.92

244

(3044640) Blood type and Crossmatch panel - Blood

445

2664

2.32

33.43

5.6

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

255

4.14

33.38

1.7

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

417

2441

2.32

32.88

5.3

3.2

1896.54

1032.25

ng/l

2.09

378

2060

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

6.72

32.74

3.0

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

441

2651

2.30

32.55

5.9

2.7

58.73

64.87

u/l

0.89

420

2458

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

200

838

2.78

32.43

5.0

2.5

0.22

0.21

g/l

0.23

194

786

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

241

4.14

31.78

3.9

2.4

13.14

12.29

mg/l

0.38

223

(3037467) Urinalysis macro (dipstick) panel - Urine

733

5536

2.73

31.27

13.9

4.5

—

3.13

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

794

6262

3.24

30.97

26.6

8.6

76.67

79.18

u/l

0.91

772

5944

(3018418) pH of Serum or Plasma

418

2496

2.26

30.89

15.7

4.1

7.39

7.40

0.45

339

1791

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

175

4.58

30.06

2.0

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

150

560

3.01

29.93

3.2

2.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

274

1384

2.41

29.84

2.9

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

704

5274

2.53

29.48

11.1

4.5

56.33

772.80

e6/l

0.90

(3045414) Leukocytes [Presence] in Urine

186

787

2.72

29.36

3.6

2.1

0.00

0.03

estimate

0.78

157

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

111

5.52

29.24

1.9

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

134

475

3.14

29.22

1.9

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

113

5.42

28.67

1.9

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

5.42

28.67

1.9

1.4

—

(3000494) Fungus identified in Specimen by Culture

230

1093

2.48

28.49

3.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.51

28.41

2.1

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

6.26

28.36

3.2

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

6.26

28.36

3.2

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

6.26

28.36

3.2

1.6

—

(3036489) Thrombin time

105

327

3.50

28.20

4.4

2.2

21.39

21.04

0.36

307

(3013826) Glucose [Moles/volume] in Serum or Plasma

657

4816

2.34

28.20

16.3

5.3

6.59

6.66

mmol/l

0.44

641

4580

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

5.87

28.15

1.7

1.3

—

(3017732) Neutrophils [#/volume] in Blood

225

1068

2.47

27.88

4.2

3.4

5.63

4.99

e9/l

0.31

176

937

(3015736) pH of Urine

522

3507

2.16

27.60

8.1

3.4

6.35

6.18

2.39

274

1986

(3002582) Erythrocytes [#/volume] in Urine

430

2683

2.15

27.54

10.4

3.3

23.93

56.84

e6/l

2.48

381

2041

(3025468) Yersinia sp identified in Specimen by Organism specific culture

107

5.41

27.22

1.9

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

107

5.41

27.22

1.9

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

108

5.36

26.95

1.9

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

761

6019

2.69

26.56

14.0

4.5

16.59

11.87

mm/h

12.04

720

5637

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

330

1883

2.19

26.30

2.9

1.8

1.59

1.24

mg/l

1.16

269

1459

(3019309) Folate [Moles/volume] in Red Blood Cells

247

1259

2.32

25.83

1.9

1.7

1188.40

1180.98

nmol/l

0.03

196

945

(3030467) Casts [#/volume] in Urine by Automated count

381

2315

2.12

25.67

9.2

3.2

0.24

0.40

e6/l

1.27

326

1682

(3035715) Granulocytes [#/volume] in Blood

147

4.53

25.21

5.5

3.3

4.46

4.32

e9/l

0.16

147

(21494815) CD4 cells/Lymphocytes in Specimen

6.31

25.20

2.1

1.8

42.04

37.30

0.82

(3020876) Protein [Mass/time] in 24 hour Urine

5.71

24.83

3.2

2.3

1.45

1.81

g/24h

0.22

(3018095) Leukocytes [#/volume] in Urine

466

3087

2.05

24.51

12.1

4.0

100.12

94.31

e6/l

0.04

384

2154

(3009261) Glucose [Presence] in Urine by Test strip

605

4415

2.12

24.36

9.5

3.8

0.01

0.39

estimate

0.51

113

809

(3003396) Base excess in Arterial blood by calculation

199

946

2.42

24.24

13.6

9.4

0.67

0.85

mmol/l

0.25

168

802

(3019977) pH of Arterial blood

200

954

2.41

24.17

13.7

9.5

7.42

0.12

527

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

200

955

2.41

24.11

13.7

9.4

5.02

5.12

kpa

0.83

190

929

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

409

2599

2.05

23.97

4.0

2.2

123.48

215.44

u/l

2.35

397

2473

(3026008) Bacteria identified in Urine by Culture

389

2428

2.06

23.95

4.8

3.0

—

(3035350) Ketones [Presence] in Urine by Test strip

600

4384

2.10

23.82

9.5

3.8

0.00

4.02

estimate

0.80

116

872

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

180

825

2.48

23.71

4.4

3.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

199

955

2.39

23.68

13.8

9.4

11.44

12.28

kpa

1.70

188

932

(3014111) Lactate [Moles/volume] in Serum or Plasma

172

774

2.51

23.55

19.8

8.5

1.29

1.32

mmol/l

0.11

165

765

(3021960) Folate [Moles/volume] in Serum or Plasma

378

2348

2.05

23.46

2.0

1.7

19.60

20.64

nmol/l

0.66

336

1976

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

29.12

23.28

2.4

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

540

3815

2.04

23.28

6.9

3.0

172.02

129.04

ug/l

2.68

509

3577

(3021601) Nitrite [Presence] in Urine by Test strip

593

4334

2.07

23.25

9.6

3.8

0.01

0.00

estimate

0.40

118

856

(3035933) Granulocytes/Leukocytes in Blood

190

3.91

22.93

5.7

3.1

60.51

58.03

0.77

190

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

466

3136

2.01

22.93

6.0

3.7

852.70

65.88

ng/l

0.47

384

2211

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

6.61

22.78

1.5

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

536

3795

2.02

22.74

5.6

2.8

—

estimate

—

(3007164) IgA [Mass/volume] in Serum or Plasma

306

1776

2.09

22.68

2.5

1.5

2.35

2.40

g/l

0.15

227

1063

(3015377) Calcium [Moles/volume] in Serum or Plasma

436

2878

2.00

22.55

6.3

3.6

2.34

2.36

mmol/l

2.61

399

2614

(3016502) Oxygen saturation in Arterial blood

181

851

2.41

22.45

14.2

9.9

94.50

95.40

0.69

176

829

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

232

3.59

22.38

2.4

1.6

—

(3026782) Osmolality of Urine

278

1564

2.12

22.31

7.2

2.8

472.42

526.32

mosm/kgh2o

5.70

255

1375

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

263

1450

2.15

22.23

6.4

3.0

0.52

1.00

e6/l

4.64

184

761

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

9.25

22.17

4.0

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

9.25

22.17

4.0

2.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

7.50

22.16

1.8

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

7.50

22.16

1.8

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

440

2926

1.98

22.15

7.8

3.4

6.41

7.72

mmol/l

9.73

402

2488

(3029937) Albumin [Presence] in Urine by Test strip

379

2399

2.00

21.93

10.2

3.8

0.00

0.01

estimate

1.34

104

815

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

173

3.97

21.87

3.4

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

205

1029

2.28

21.82

5.6

4.9

33.04

32.21

0.50

159

684

(3012516) Albumin [Mass/volume] in Urine

416

2732

1.97

21.53

7.3

3.5

119.24

44.47

mg/l

3.44

317

1713

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

149

4.17

21.31

2.1

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

184

3.79

20.81

2.1

1.5

—

(4035726) Immunohistochemistry procedure

162

750

2.41

20.68

2.0

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

8.61

20.22

4.3

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

415

2776

1.92

19.86

8.4

4.1

22.39

7.82

mg/mmol

3.07

310

1692

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

6.42

19.85

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

236

3.38

19.71

1.8

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

7.27

19.59

4.1

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

7.27

19.59

4.1

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

7.27

19.59

4.1

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

7.27

19.59

4.1

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

156

3.90

19.23

10.9

2.8

11.34

8.56

pmol/l

1.26

156

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

7.38

19.16

1.9

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

7.38

19.16

1.9

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

151

701

2.39

19.06

6.6

2.3

0.29

0.45

e6/l

0.50

144

668

(40760892) CBC W Ordered Manual Differential panel - Blood

309

1896

1.96

18.95

12.9

4.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

137

611

2.46

18.89

1.7

1.3

249.16

218.61

u/ml

0.15

129

572

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

137

4.05

18.55

1.2

2.35

5.80

u/ml

1.13

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

6.57

18.47

1.0

1.1

1589.17

1633.74

miu/ml

0.06

(3037756) Immunofixation for Serum or Plasma

180

3.62

18.42

2.2

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

4.79

18.37

1.9

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.11

18.34

2.6

2.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

148

3.89

18.22

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

148

3.89

18.22

1.6

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

256

3.15

17.86

1.4

1.2

17.18

9.94

u/ml

—

(3004616) Nuclear Ab [Presence] in Serum

102

4.48

17.74

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

256

3.10

17.24

1.4

1.2

2.18

2.47

u/ml

—

(3051651) Icteric interference index of Serum or Plasma

5.91

17.21

4.3

3.0

0.71

0.87

index

0.66

(3034860) Kappa light chains.free [Mass/volume] in Serum

262

3.08

17.17

4.6

4.0

54.43

71.71

mg/l

0.32

224

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

262

3.08

17.17

4.6

4.0

37.02

55.93

mg/l

0.63

224

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

254

3.08

16.84

2.2

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

103

423

2.62

16.81

1.8

1.4

—

(40768441) Liver Pathology biopsy report

5.03

16.74

2.7

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

203

1120

2.05

16.52

4.0

2.4

220.26

115.94

ug/g

1.52

174

907

(3021901) Oxygen saturation in Capillary blood

180

3.44

16.26

11.2

2.7

92.12

89.87

2.01

175

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

184

988

2.08

16.08

10.8

2.9

5.65

7.45

umol/l

2.17

169

880

(3015171) Extractable nuclear Ab [Units/volume] in Serum

339

2.73

15.73

1.4

1.2

0.24

1.46

u/ml

0.75

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

4.81

15.52

3.7

2.3

—

(3023419) Bacteria identified in Sputum by Culture

132

3.78

15.43

5.0

2.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

4.34

15.18

2.3

1.6

45.00

60.43

1.39

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

334

2.71

15.11

2.4

2.5

4.22

4.24

g/l

0.05

309

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

334

2.71

15.11

2.4

2.5

3.24

3.75

g/l

2.98

309

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

334

2.71

15.11

2.4

2.5

7.23

7.34

g/l

0.23

309

(3023183) Ammonium ion [Moles/volume] in Plasma

190

3.25

14.93

5.0

3.6

38.93

34.35

umol/l

0.33

175

(3003327) Ova and parasites identified in Stool by Light microscopy

285

2.82

14.77

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

132

3.70

14.66

1.2

2.12

4.86

u/ml

0.79

(3000475) Leukocytes [#/volume] in Synovial fluid

226

3.02

14.47

2.0

1.6

4953.67

13314.88

e6/l

2.04

163

(3052851) Hemolysis interference index of Serum or Plasma

233

2.98

14.30

4.4

3.1

3.32

2.39

index

0.37

132

(3028679) Herpes simplex virus Ab [Presence] in Serum

5.79

14.20

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

240

2.94

14.15

4.7

3.8

3.85

4.16

ratio

0.05

134

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.90

14.10

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.81

13.37

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

265

2.78

13.36

1.5

1.4

291.49

294.80

ug/g

0.04

158

(40758558) Short blood count panel - Blood

364

2554

1.71

13.29

14.4

6.4

—

(40768804) Tissue Pathology biopsy report

442

3268

1.69

13.27

2.9

2.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

320

2.61

13.22

2.5

2.90

2.98

g/l

0.26

295

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

128

3.56

13.05

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2.67

12.87

2.3

2.6

8.53

10.60

g/l

3.68

262

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

220

1346

1.84

12.83

7.6

3.1

1.54

2.28

e6/l

0.83

140

655

(3007566) Smooth muscle Ab [Titer] in Serum

260

2.75

12.74

1.8

1.2

50.00

95.00

titre

—

(40768443) Skin Pathology biopsy report

370

2.46

12.69

1.4

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

167

3.18

12.57

2.6

1.9

4.41

5.01

mmol/24h

0.69

148

(1616796) Gas panel - Central venous blood

179

3.08

12.41

8.2

3.2

—

(3025941) Bacteria identified in Stool by Culture

432

2.34

12.40

1.6

1.2

—

(3013512) EKG study

392

2852

1.66

12.19

5.4

3.4

—

0.70

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

473

3615

1.65

12.08

2.6

2.1

98.95

97.08

pmol/l

0.34

284

1895

(3022145) Colonoscopy Study observation

171

987

1.90

11.89

1.6

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

295

2.57

11.77

3.1

2.7

0.40

1.00

g/l

1.09

261

(1761868) Lipid panel - Serum or Plasma

219

3238

0.57

11.43

3.8

3.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

20.33

11.15

12.6

6.1

5.52

5.20

mmol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

10.21

11.04

4.3

1.5

—

(4268621) Lupus anticoagulant assay

3.68

11.00

2.3

—

(40768797) Stomach Pathology biopsy report

193

1184

1.80

10.98

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

3.10

10.51

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

7.84

10.43

1.2

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

4.36

10.35

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

118

629

2.01

10.28

2.2

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

119

3.29

10.09

1.2

120.55

115.90

0.32

114

(3009871) Measles virus Ab [Titer] in Serum

5.22

9.87

1.6

1720.00

6400.00

titre

—

(3021589) Normoblasts [#/volume] in Blood

473

3726

1.57

9.85

30.2

11.2

0.00

e9/l

0.05

410

3020

(3044927) Protein electrophoresis panel - Urine

3.65

9.72

1.3

1.1

—

(3012501) Base excess in Blood by calculation

144

3.01

9.62

8.0

3.8

2.15

2.53

mmol/l

0.37

102

(3020393) Adenovirus Ag [Presence] in Stool

17.75

9.42

3.4

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

108

576

1.99

9.38

2.6

2.5

7.78

16.62

au/ml

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

378

2855

1.56

9.33

9.1

3.4

30.29

32.58

u/l

0.74

361

2708

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

3.89

9.28

1.6

1.1

610.00

107.50

titre

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

418

2.14

9.17

8.6

3.5

57.20

48.77

2.20

411

(3010144) Erythrocytes [#/volume] in Synovial fluid

3.57

9.13

1.6

1.3

28861.16

159871.13

e6/l

0.92

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

177

2.75

9.10

1.7

1.1

—

(3017704) Immunofixation for Urine

4.85

9.09

1.3

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

9.16

9.05

3.9

1.9

0.07

0.30

e9/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

244

2.47

9.00

1.5

1.4

14.09

9.18

u/l

1.03

194

(21494890) Protein electrophoresis panel - 24 hour Urine

3.67

8.89

2.9

2.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

216

2.54

8.79

3.8

2.2

124.97

131.41

g/l

0.93

172

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

240

1654

1.61

8.66

1.4

1.3

57.78

31.24

iu/ml

1.02

524

(3001964) Herpes simplex virus Ag [Presence] in Specimen

8.32

8.60

2.8

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

10.16

8.55

1.5

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

137

816

1.80

8.46

5.8

2.6

42.19

41.06

u/l

0.06

121

694

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

882

0.36

8.40

2.1

2.0

3.37

3.53

ratio

0.34

709

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.42

8.18

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

11.83

8.09

2.2

1.4

—

(3049717) Cytology report of Urine Cyto stain

296

2.25

8.04

2.7

2.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

234

1628

1.59

8.04

1.6

1.7

34826303.58

20634177.00

pmol/l

0.16

201

1357

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

113

646

1.86

7.96

2.9

2.4

11.37

7.34

ug/l

0.90

101

584

(3008152) Bicarbonate [Moles/volume] in Arterial blood

492

1.97

7.92

9.9

8.1

24.36

24.50

mmol/l

0.13

474

(3008898) HLA-B27 [Presence]

313

2.20

7.81

1.3

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.93

7.73

2.3

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

117

683

1.82

7.71

2.0

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

212

2.44

7.65

1.5

1.2

—

(3003181) Sodium [Moles/volume] in Urine

158

2.67

7.62

2.2

1.3

57.38

61.54

mmol/l

0.28

139

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.60

7.46

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

196

2.47

7.46

1.6

1.2

3.78

mmol/l

0.01

184

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.46

7.45

1.1

—

(4195642) Thrombophilia screening test

116

2.91

7.28

1.2

—

(3042631) Mycobacterium sp identified in Specimen

106

2.99

7.18

3.1

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

143

905

1.69

7.09

11.7

6.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

4.25

7.03

1.3

1.0

0.93

1.12

u/l

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

661

0.33

7.01

1.9

1.8

3.57

3.50

mmol/l

0.08

489

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

13.90

6.90

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

510

1.87

6.82

2.6

3.4

4.34

4.59

pmol/l

1.27

454

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

9.40

6.80

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.94

6.73

1.3

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

252

2.22

6.67

2.7

2.8

0.00

g/l

-0.00

221

(3016018) Differential panel - Cerebral spinal fluid

3.12

6.51

1.7

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

203

2.33

6.48

1.4

1.2

65.02

47.02

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.03

6.43

1.3

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

14.43

6.40

1.9

4.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

103

2.88

6.31

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

214

1536

1.52

6.21

1.4

1.3

28.10

14.22

u/ml

0.93

579

(3000093) Morphology [Interpretation] in Blood Narrative

3.07

6.11

1.5

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

100

2.86

6.04

1.2

1.1

94.50

97.17

0.19

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.08

6.01

2.1

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

147

2.51

6.01

1.2

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

838

7872

1.91

5.96

54.3

15.7

20.58

23.40

mg/l

1.73

793

6458

(3016650) Hepatitis A virus Ab [Presence] in Serum

155

2.45

5.86

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

131

2.58

5.84

2.8

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

218

1591

1.49

5.79

7.0

4.0

353.57

424.18

ng/l

0.21

175

1227

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

2.78

5.57

3.4

2.5

16.92

18.88

mg/l

0.18

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.55

5.57

1.2

84.09

95.77

0.48

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.55

5.57

1.3

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.86

5.55

1.4

2.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

5.43

5.55

2.1

1.4

25.33

33.64

1.23

(3047181) Lactate [Moles/volume] in Blood

231

2.14

5.53

7.8

8.8

1.28

1.29

mmol/l

0.02

206

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

3.11

5.52

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

129

848

1.61

5.48

3.2

4.6

10.12

23.58

ug/l

0.69

109

705

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

7.14

5.45

1.7

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

174

2.30

5.40

1.8

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

3.14

5.37

3.2

2.9

43.29

38.20

0.61

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

627

5566

1.41

5.33

8.1

3.4

61.04

49.85

u/l

2.05

601

5255

(3020717) Zinc [Moles/volume] in Serum or Plasma

3.45

5.32

2.9

1.4

10.10

22.94

umol/l

2.40

(40757373) Influenza virus identified in Isolate

6.74

5.26

3.3

1.7

—

(3002256) Pathology report gross observation

156

1082

1.53

5.25

1.5

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.45

5.24

1.3

1.2

38.43

38.20

g/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

5.21

2.2

0.0

—

(3032057) Clostridioides difficile [Presence] in Stool

6.94

4.96

2.4

2.0

—

(3014271) Vancomycin [Susceptibility]

4.38

4.95

2.4

2.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

4.38

4.95

4.9

1.6

2.59

1.84

umol/l

0.95

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.71

4.94

6.4

3.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

215

1610

1.44

4.93

3.6

3.0

2.47

2.45

mmol/l

1.47

195

1450

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.76

4.86

1.8

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.76

4.86

1.8

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.76

4.86

1.8

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.03

4.85

2.8

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

11.52

4.79

2.0

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.06

4.64

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

3.53

4.63

1.3

1.2

224.87

567.55

u/l

0.72

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.38

4.62

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

187

2.13

4.58

1.6

1.5

28.50

14.17

e6/l

0.35

138

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

161

2.22

4.55

1.3

1.2

57.97

16.11

u/l

0.97

137

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.73

4.44

1.2

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

224

2.01

4.43

1.5

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

190

2.10

4.41

1.7

1.5

20.25

1153.71

e6/l

0.93

146

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.69

4.38

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.77

4.37

1.5

1.1

100.10

108.79

pmol/l

0.47

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.99

4.30

2.4

1.6

—

(4015189) Microbial culture of sputum

6.31

4.30

1.3

2.7

—

(3019174) dRVVT (LA screen)

8.96

4.28

1.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.54

4.24

1.2

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

390

3284

1.33

4.22

10.2

3.6

0.05

0.02

estimate

0.31

101

710

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.85

4.19

1.8

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.83

4.14

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

2.66

4.08

1.7

1.3

2346.25

1980.73

e6/l

0.15

(3014765) Yersinia sp identified in Stool by Organism specific culture

224

1.97

4.08

1.5

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.29

3.92

6.6

3.0

0.86

1.26

0.50

(21494434) Karyotype in Bone marrow

2.67

3.92

1.6

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

228

1.93

3.89

1.6

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

386

1.71

3.82

2.4

2.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.05

3.82

1.0

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

3.22

3.79

1.2

1.1

0.52

0.51

ratio

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.22

3.79

1.1

1.6

—

364639.80

iu/ml

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.81

3.77

9.4

4.4

—

(3045142) Bone marrow Pathology biopsy report

2.43

3.75

1.9

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

558

4996

1.31

3.67

3.6

3.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.54

3.61

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.54

3.61

1.5

1.6

—

(3034891) Synovial lining cells/cells in Synovial fluid

3.75

3.60

3.1

1.3

2.75

2.00

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

7.83

3.56

1.0

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.27

3.51

1.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.86

3.37

2.7

1.6

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

5.75

3.34

3.3

1.4

1.12

1.38

umol/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

205

1.89

3.30

2.1

2.0

139.34

4321.55

u/l

1.88

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

335

1.68

3.21

3.3

3.5

26.87

4093.23

u/ml

0.77

289

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

144

2.05

3.18

1.1

—

1.19

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.76

3.16

2.7

1.6

—

(3034426) Prothrombin time (PT)

4.03

3.09

1.1

1.4

28.00

28.76

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

246

2014

1.30

3.07

1.4

1.3

2.72

1.56

u/ml

0.46

539

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.92

3.03

3.0

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.87

3.02

3.3

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.58

2.99

2.4

2.1

10686.67

3879.69

e6/l

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.47

2.90

1.0

1.1

51.00

99.43

ng/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

270

1.70

2.80

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.19

2.78

1.3

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

8.37

2.75

1.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.03

2.73

1.0

—

(3000012) Reticulocyte production index

105

2.12

2.70

8.3

2.5

1.04

0.93

0.32

(3044941) Cell count panel - Synovial fluid

161

1.89

2.69

1.9

1.4

—

(3022621) pH of Urine by Test strip

659

1.44

2.66

3.3

2.3

6.06

6.08

0.08

429

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.68

2.63

6.0

1.6

26.38

29.98

umol/l

0.85

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.69

2.60

1.1

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.69

2.60

1.4

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.75

2.55

1.1

1.3

159.92

152.45

nmol/l

0.12

(3002079) Sodium [Moles/time] in 24 hour Urine

2.88

2.55

1.0

1.4

177.08

182.97

mmol/24h

0.07

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

7.18

2.55

1.2

1.9

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.18

2.55

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.48

2.54

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.62

2.54

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.52

2.54

3.6

1.8

212.59

101.67

ng/l

1.10

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

102

2.08

2.49

8.6

2.3

33.48

32.67

0.43

102

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.15

2.44

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.15

2.44

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.15

2.44

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.15

2.44

1.1

—

(21494755) Public health laboratory ask at order entry panel

755

0.64

2.43

1.2

1.4

—

(3012441) Differential panel - Pleural fluid

2.31

2.42

1.6

1.4

—

(40768806) Pleura Pathology biopsy report

2.31

2.42

1.3

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.36

2.39

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.09

2.38

1.1

—

(3033799) Differential panel - Peritoneal fluid

3.05

2.36

1.9

1.5

—

(40765096) Chromosome analysis panel by Banding

3.05

2.36

1.3

1.1

—

(3019150) Specific gravity of Urine by Refractometry

231

1940

1.26

2.29

11.5

3.7

1.02

1.79

kg/l

0.50

170

1303

(4034850) Laboratory test

247

1.65

2.28

12.6

9.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.57

2.27

1.1

1.2

—

(3000492) Spirometry study

115

883

1.35

2.24

2.2

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.58

2.21

2.8

1.4

54.80

38.00

umol/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

5.58

2.21

1.8

3.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5.58

2.21

3.8

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

5.58

2.21

1.0

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.58

2.21

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

158

1.80

2.19

1.3

1.1

5.43

6.10

u/ml

0.07

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.35

2.18

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

274

2359

1.23

2.16

8.1

3.2

0.23

0.05

estimate

0.43

102

686

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.31

2.15

1.5

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

4.31

2.15

1.3

1.5

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

4.31

2.15

14.2

1.9

1.25

1.26

mmol/l

—

(3047189) Immunofixation for 24 hour Urine

2.64

2.14

2.9

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

182

1.73

2.14

1.4

1.1

2.59

1.48

u/ml

0.19

106

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.38

2.13

3.3

1.9

—

(3045788) Cell count panel - Pleural fluid

2.23

2.12

1.9

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.22

2.10

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

265

2282

1.23

2.07

1.6

1.4

—

(44806071) Cardiolipin IgM antibody measurement

5.02

2.07

1.0

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

835

8100

1.42

2.02

56.8

18.4

139.44

139.71

mmol/l

2.35

816

7964

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.10

2.01

1.3

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.83

2.00

7.3

4.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

668

6304

1.23

2.00

5.6

4.4

15.07

14.75

pmol/l

2.37

627

5819

(3017446) Testosterone [Moles/volume] in Serum or Plasma

722

1.35

1.99

2.7

2.3

12.63

13.35

nmol/l

0.47

662

(3018333) Ribosomal P Ab [Presence] in Serum

2.10

1.97

1.3

1.1

—

(40761536) Microorganisms panel - Urine sediment

637

1.37

1.95

11.2

3.9

—

(3033099) Centromere Ab [Titer] in Serum

4.56

1.94

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.98

1.94

1.3

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.74

1.93

2.4

2.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

835

8108

1.40

1.93

58.3

18.5

4.00

3.97

mmol/l

2.40

815

7957

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.13

1.93

1.8

1.4

10144.30

42114.94

e6/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

407

0.58

1.92

1.6

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.07

1.91

1.3

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

151

1.74

1.88

1.9

3.2

0.98

0.85

nmol/l

0.46

124

(44816559) Phosphatidylethanol [Mass/volume] in Blood

393

1.45

1.87

2.1

1.7

0.48

0.36

mg/l

0.65

182

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.87

1.86

2.1

1.9

40.23

41.52

g/l

—

(40758292) HTLV I+II Ab panel - Serum

3.55

1.84

1.2

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.55

1.84

15.5

1.7

1.22

1.21

mmol/l

—

(36660697) Celiac disease serology panel - Serum

723

1.34

1.84

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.18

1.82

1.4

3.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.18

1.82

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

4.18

1.82

1.0

5.67

6.38

mg/g

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.02

1.80

1.4

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

3.06

1.80

4.0

1.0

16.24

17.85

umol/l

—

(1002224) Polysomnography panel

423

0.60

1.79

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.36

1.78

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.95

1.75

1.4

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.51

1.74

3.1

2.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.93

1.72

1.0

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.86

1.71

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.86

1.71

1.2

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.97

1.70

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.97

1.70

1.4

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.59

1.66

2.4

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.40

1.62

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

151

1.67

1.61

1.3

1.1

1.33

1.49

u/ml

0.05

(3003740) Influenza virus B Ag [Presence] in Specimen

151

1.67

1.61

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.92

1.60

1.4

1.1

—

(3006462) Nitrate [Presence] in Urine

2.51

1.60

2.0

3.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.51

1.60

1.0

—

(3008295) Osmolality of Serum or Plasma

106

1.81

1.59

1.5

285.18

278.19

mosm/kgh2o

0.47

(4094501) Cardiovascular stress test using bicycle ergometer

247

0.52

1.57

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

125

1023

1.26

1.55

2.2

1.8

1.55

1.48

0.50

106

897

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

296

0.57

1.54

1.1

1.47

1.55

g/l

0.85

296

(3024869) Neuronal Ab [Presence] in Serum

3.35

1.52

1.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

779

8010

0.80

1.49

7.7

5.9

2.55

2.74

mmol/l

8.08

729

7492

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

237

1.50

1.44

1.1

1.3

182.43

199.74

miu/ml

—

116

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

789

7653

1.25

1.41

40.6

15.2

73.35

81.99

ml/min/173m2

16.34

752

7096

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

198

1.53

1.39

5.1

2.3

56.00

74.20

ug/min

0.26

115

(3013139) Helicobacter pylori Ag [Presence] in Stool

592

0.71

1.37

1.2

—

(3048879) Bone marrow aspiration report

2.95

1.36

3.2

2.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.34

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

149

0.47

1.32

1.1

1.6

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.51

1.30

1.2

—

(4146454) Self-monitoring of blood glucose

1.77

1.29

3.0

2.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.01

1.27

1.5

1.6

—

22.33

—

(40768795) Lymph node Pathology biopsy report

1.80

1.27

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.30

1.27

1.6

1.2

11.25

8.80

ug/l

—

(3023410) Appearance of Cerebral spinal fluid

1.75

1.25

1.9

1.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.23

1.24

1.1

1.0

—

(4211845) Urine protein measurement

2.23

1.24

2.0

3.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.51

1.15

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

388

1.33

1.14

1.6

1.4

29.85

27.75

iu/l

0.11

334

(3043410) Blood group antigens tested for on Red Blood Cells

2.34

1.12

3.3

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

152

1.53

1.09

1.4

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

400

1.32

1.09

1.6

1.3

—

(40768800) Prostate Pathology biopsy report

164

0.54

1.09

1.0

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

205

0.58

1.07

1.2

1.9

—

(3027944) Amphetamines [Presence] in Urine

300

0.66

1.05

1.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

300

0.66

1.05

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

300

0.66

1.05

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

276

0.65

1.04

1.3

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.28

1.03

36.6

7.2

9.26

5.27

kpa

—

(3000764) Benzodiazepines [Presence] in Urine

297

0.67

1.01

1.3

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

850

8611

0.78

0.95

73.0

24.1

128.22

135.84

g/l

35.95

839

8539

(3023430) Cat dander IgE Ab [Units/volume] in Serum

125

1.53

0.94

1.1

11.86

6.19

u/ml

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.23

0.93

1.3

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

142

1.49

0.93

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.74

0.92

1.2

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

128

1465

0.85

0.92

3.1

0.69

0.74

ug/l

0.33

921

(3026361) Erythrocytes [#/volume] in Blood

850

8608

0.78

0.91

72.6

23.9

4.28

4.51

e12/l

24.97

836

8430

(3035941) MCH [Entitic mass]

850

8608

0.78

0.91

72.2

23.9

30.23

30.34

0.85

839

8538

(3010813) Leukocytes [#/volume] in Blood

850

8608

0.78

0.91

72.7

24.0

7.34

6.66

e9/l

14.28

836

8429

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

850

8608

0.78

0.91

75.6

24.5

39.03

40.51

16.41

839

8533

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

228

1.37

0.89

2.6

1.9

2.93

3.87

iu/l

0.73

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.08

0.89

1.3

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

152

1.46

0.88

1.3

1.1

0.81

1.77

u/ml

0.60

(3024731) MCV [Entitic mean volume] in Red Blood Cells

850

8606

0.79

0.88

72.3

23.9

92.04

91.05

6.81

839

8536

(3007461) Platelets [#/volume] in Blood

850

8605

0.79

0.87

72.8

24.0

259.37

252.41

e9/l

1.98

837

8454

(3025130) Human papilloma virus identified in Specimen

104

1.55

0.85

2.0

1.7

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

1.88

0.82

1.8

1.1

—

84.60

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

175

1939

0.88

0.81

3.7

4.3

23.41

21.01

1.18

894

(3014133) Dog dander IgE Ab [Units/volume] in Serum

131

1.46

0.79

1.1

5.97

2.92

u/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

776

7908

0.87

0.77

7.2

5.2

4.54

4.68

mmol/l

3.30

728

7415

(3005570) Glucose [Moles/volume] in Urine

1.55

0.75

1.5

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

107

0.56

0.73

1.2

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

229

0.69

0.71

1.4

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.93

0.70

1.2

1.6

3113.60

68.54

nmol/24h

—

(3050129) First trimester maternal screen panel - Serum or Plasma

144

0.62

0.70

1.9

1.5

—

(44813793) Dust mix specific IgE antibody measurement

1.53

0.68

1.3

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

380

3603

1.09

0.67

2.4

2.0

1.56

1.37

mmol/l

3.53

337

3068

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.79

0.66

3.6

3.5

12.19

10.46

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.79

0.66

3.6

3.5

4.66

4.91

kpa

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

111

1.45

0.66

1.1

1.0

0.30

0.58

u/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

154

1.37

0.65

1.6

1.7

—

(3024263) Appearance of Synovial fluid

1.60

0.65

2.7

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.60

0.0

1.4

—

0.71

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

775

7876

0.89

0.60

7.2

5.1

1.47

mmol/l

0.14

725

7351

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.51

0.58

2.3

1.4

84.00

73.81

umol/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.58

0.0

1.0

—

(40761511) CBC panel - Blood by Automated count

825

8142

1.16

0.57

40.5

13.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.46

0.56

1.1

3.1

8.40

8.43

mmol/l

—

(4281824) Cell count and differential, peritoneal fluid

100

0.60

0.52

1.7

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

324

1.21

0.51

1.5

1.6

6.52

9.90

u/ml

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

755

7423

1.10

0.51

6.9

5.4

1.96

1.91

mu/l

0.54

712

6897

(40768793) Breast Pathology biopsy report

224

0.75

0.50

1.5

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

253

1.23

0.49

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

208

1.26

0.48

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

128

1.33

0.48

1.1

5.69

2.11

eliau/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

760

7710

0.91

0.46

8.0

5.2

5.87

5.94

mmol/l

0.82

713

7130

(3017569) Oxygen content in Arterial blood

1.43

0.46

2.0

3.3

16.54

16.94

—

(1761482) Bacteria [#/volume] in Urine by Culture

185

0.75

0.43

6.7

4.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

273

0.80

0.43

1.7

1.4

—

(44806420) Estimation of glomerular filtration rate

0.64

0.42

2.0

2.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.59

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.55

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.40

0.0

1.4

—

64.76

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

863

0.89

0.40

1.8

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

102

0.68

0.39

1.4

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

105

0.66

0.39

1.4

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.39

0.0

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

125

1.29

0.37

2.2

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.29

0.36

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

122

0.74

0.35

1.4

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

339

0.85

0.33

1.6

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

847

8415

1.11

0.28

60.8

20.4

99.73

75.59

umol/l

15.66

835

8336

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

119

1261

0.94

0.26

1.6

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.69

0.26

3.6

2.3

52.00

33.96

mg/l

—

(3028707) Methadone [Presence] in Urine by Screen method

138

0.79

0.25

1.4

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.24

0.25

1.2

1.1

—

6.36

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.25

0.22

1.0

1.1

82.46

172.73

iu/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.13

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.21

0.0

2.1

—

3.60

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

7.69

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

11.00

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.23

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

918

1.06

0.20

1.5

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

841

8365

1.08

0.20

37.2

12.4

26.23

26.65

u/l

0.28

825

8160

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

1.78

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

59.43

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.20

0.19

1.2

30.67

8.68

mm/h

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

127

1.18

0.19

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.15

0.19

1.2

1.5

5.15

6.38

ug/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

589

0.93

0.18

1.2

56.76

131.17

u/ml

2.03

245

(3000034) Microalbumin [Mass/volume] in Urine

0.71

0.16

10.4

3.2

329.94

16.01

mg/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

801

0.94

0.16

2.2

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.20

0.16

3.5

2.6

1.19

mmol/l

0.10

(3036782) Glucose [Moles/volume] in Pleural fluid

1.10

0.15

1.3

7.49

6.37

mmol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

103

1.17

0.13

1.3

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

726

1.05

0.13

2.0

1.9

—

(3041354) Potassium [Moles/volume] in Venous blood

1.17

0.13

3.5

2.6

4.15

4.01

mmol/l

0.35

(3035285) Chloride [Moles/volume] in Venous blood

1.17

0.13

3.5

2.6

106.09

105.12

mmol/l

0.55

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

108

0.83

0.13

1.7

1.3

—

nmol/l

—

(4024509) Urine culture

394

1.07

0.12

2.1

2.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

749

7531

0.97

0.12

6.3

4.4

1.48

1.30

mmol/l

8.94

693

6969

(3023511) Choriogonadotropin [Units/volume] in Urine

116

0.86

0.12

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

402

0.94

0.10

1.7

2.0

—

(3025577) Chromium [Mass/volume] in Blood

1.11

0.10

2.6

2.3

1.60

2.22

ug/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.05

0.08

1.5

1.1

—

(3004451) EKG impression Narrative

1.03

0.08

1.5

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

123

0.89

0.08

1.6

1.3

73.28

0.62

nmol/l

0.47

117

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

441

1.05

0.07

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

757

7550

1.02

0.05

10.2

6.4

39.62

39.21

mmol/mol

0.58

707

7112

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

243

2408

1.01

0.04

4.5

5.3

1.90

2.23

ug/l

0.73

216

2194

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

129

0.93

0.03

1.6

1.2

—

0.50

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

168

0.95

0.02

4.8

3.6

21.37

23.45

mg/l

0.07

112

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

149

1499

0.99

0.01

1.7

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

236

0.97

0.00

1.9

188.52

213.96

pmol/l

0.67

223

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

294

1.02

0.00

1.9

36.77

39.76

nmol/l

0.38

283

(3038177) Helicobacter pylori Ab [Presence] in Serum

133

0.98

0.00

1.0

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

77.66

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

30.00

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

635.60

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

0.44

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.4

—

6.00

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.0

—

7.78

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

74.00

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

355.50

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

5.2

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.7

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

-0.00

0.0

5.8

—

0.15

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_CATAR and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_CATAR	3.266 [2.86, 3.73]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.061

During the follow-up period (1.1.1998 — 31.12.2019), 634 out of 2151 females with DRUGADVERS_CATAR died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_CATAR	3.542 [3.09, 4.06]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 578 out of 1606 males with DRUGADVERS_CATAR died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_CATAR.

N-year risk	Females	Males
1	0.22%	0.562%
5	2.003%	3.4%
10	4.599%	9.293%
15	8.461%	17.053%
20	13.692%	27.482%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_CATAR – Drug-induced cataract

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced cataract

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints